跳至主要内容
临床试验/NCT06390228
NCT06390228已完成不适用

Impact of Major Hepatectomy on Recurrence After Resection of Hepatocellular Carcinoma at China Liver Cancer Staging (CNLC) Stage : a Propensity Score Matching Study

Anhui Medical University1 个研究点 分布在 1 个国家目标入组 197 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
197
试验地点
1
主要终点
recurrence-free survival

研究概览

简要总结

Hepatectomy is the first option for the treatment of hepatocellular carcinoma(HCC) at CNLC Ib stage. HCC patients who undergo curative hepatectomy may experience varying remnant liver volumes and thus leads to different oncological outcomes.

详细描述

Patients with hepatocellular carcinoma (HCC) who undergo curative hepatectomy may experience varying remnant liver volumes. The investigators aimed to evaluate whether the extent of liver resection has an effect on postoperative recurrence in HCC patients. A retrospective analysis was conducted on 197 patients who underwent hepatectomy for a solitary HCC lesion measuring ≥5 cm between January 2019 and June 2022. Patients were divided into major hepatectomy (MAH) group (n=70) and minor hepatectomy (MIH) group (n=127) based on the extent of liver resection. Recurrence-free survival (RFS) was compared between the two groups. Propensity score matching was employed to mitigate potential biases in this research.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • histologically confirmed solitary HCC with a size of ≥5 cm
  • Eastern Cooperative Oncology Group score of 0 or 1
  • preoperative indocyanine green retention rate at 15 minutes ≤15% and Child-Pugh A classification
  • no evidence of vascular invasion or extrahepatic disease.

排除标准

  • not diagnosed with HCC or had an HCC measuring <5 cm
  • had confirmed tumor metastases or macrovascular invasion based on radiological examinations
  • died within 90 days after surgery were excluded

结局指标

主要结局

recurrence-free survival

时间窗: 2019.1-2023.8

the time from the time of radical surgery to the time of HCC recurrence

次要结局

未报告次要终点

研究者

发起方
Anhui Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kunyuan Jiang

Clinical Professor

Anhui Medical University

研究点 (1)

Loading locations...

相似试验